PubMed Central (PMC) Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2008 | 55 |
| 2009 | 63 |
| 2010 | 57 |
| 2011 | 69 |
| 2012 | 85 |
| 2013 | 93 |
| 2014 | 113 |
| 2015 | 118 |
| 2016 | 466 |
| 2017 | 171 |
| 2018 | 144 |
| 2019 | 146 |
| 2020 | 239 |
| 2021 | 184 |
| 2022 | 116 |
| 2023 | 19 |
| 2024 | 20 |
| 2025 | 21 |
| 2026 | 9 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Ann Oncol"[Journal]
2,188
results
Embargoed Articles:
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo).
- Hahn AW, Chahoud J, Skelton WP, Yuan Y, Zurita-Saavedra AJ, Kovitz C, Alhalabi O, Campbell MT, Jonasch E, Lin JK, Desai M, Santos MJMN, Hwang H, Corn PG, Msaouel P, Tannir NM.
- Ann Oncol. Author manuscript. 2025 Oct 18;37(2):241-249. doi: 10.1016/j.annonc.2025.10.009.
- PMCID: PMC12641504
Hahn AW, et al.Ann Oncol. Author manuscript. 2025.PMCID: PMC12641504 -
Efficacy assessment in phase I clinical trials: endpoints and challenges.
- Gouda MA, Ballesteros PA, Garrido-Laguna I, Rodon J.
- Ann Oncol. Author manuscript. 2025 Mar 4;36(5):507-519. doi: 10.1016/j.annonc.2025.02.010.
- PMCID: PMC13634258
Gouda MA, et al.Ann Oncol. Author manuscript. 2025.PMCID: PMC13634258 -
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.
- Motzer RJ, Escudier B, Burotto M, Powles T, Apolo AB, Bourlon MT, Shah AY, Porta C, Suárez C, Barrios CH, Richardet M, Gurney H, Kessler ER, Tomita Y, Bedke J, Scheffold C, Askelson M, Panzica J, Zhang J, van Kooten Losio M, Choueiri TK.
- Ann Oncol. Author manuscript. 2025 Sep 23;37(1):33-43. doi: 10.1016/j.annonc.2025.09.006.
- PMCID: PMC12522107
Motzer RJ, et al.Ann Oncol. Author manuscript. 2025.PMCID: PMC12522107 -
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.
- Philips R, Mahajan A, Estephan L, Auger S, Haque W, Palmer D, McQueen J, MacCracken E, Argyris PP, Trzcinska A, Cipriani NA, Lingen M, Hussain I, Muzaffar M, Pasternak-Wise O, Curry J, Katipally R, Juloori A, Haraf D, Heinlen P, Choudhury NJ, Rosenberg A, Vokes E, Arshad H, Blair E, Agrawal N, Shah S, Pearson AT.
- Ann Oncol. Author manuscript. 2026 Jun 10;37(10):1437-1449. doi: 10.1016/j.annonc.2026.05.709.
- PMCID: PMC13557418
Philips R, et al.Ann Oncol. Author manuscript. 2026.PMCID: PMC13557418 -
Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial.
- Pagani O, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Warner E, Amant F, Mailliez A, Moore HCF, Ruiz-Borrego M, Walshe JM, Borges VF, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Klar NJ, Ferreiro T, Ribi K, Ruddy KJ, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Partridge AH; International Breast Cancer Study Group and the POSITIVE Trial Consortium.
- Ann Oncol. Author manuscript. 2026 May 28;37(9):1230-1241. doi: 10.1016/j.annonc.2026.05.699.
- PMCID: PMC13501236
Pagani O, et al.Ann Oncol. Author manuscript. 2026.PMCID: PMC13501236 -
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
- Kalinsky K, Barlow WE, Pathak HB, Puri RV, Mitra A, Home T, Gralow J, Albain KS, Hayes DF, Delaloge S, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Rastogi P, Schott AF, Brain E, Pierga JY, Ferrero JM, Shak S, Tripathy D, Hortobagyi GN, Meric-Bernstam F, Sharma P, Pusztai L, Thompson A, Godwin AK.
- Ann Oncol. Author manuscript. 2026 Jul 24;37(9):1220-1229. doi: 10.1016/j.annonc.2026.05.697.
- PMCID: PMC13488494
Kalinsky K, et al.Ann Oncol. Author manuscript. 2026.PMCID: PMC13488494 -
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
- Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Rubovszky G, Tondini C, Ciruelos EM, Gomez HL, Bonnefoi HR, Burstein HJ, Chini C, Puglisi F, Spazzapan S, Bernardo A, Climent MA, Bellet M, Ruhstaller T, Bermejo B, Chia SKL, Martino S, Geyer CE, Goetz MP, Ingle JN, Stearns V, Davidson NE, Le Du F, Müller B, Coleman RE, Loibl S, Winer EP, Ruepp B, Loi S, Láng I, Coates AS, Gelber RD, Goldhirsch A, Regan MM; International Breast Cancer Study Group; SOFT and TEXT Investigators.
- Ann Oncol. Author manuscript. 2026 Jun 1;37(10):1367-1385. doi: 10.1016/j.annonc.2026.05.704.
- PMCID: PMC13484932
Francis PA, et al.Ann Oncol. Author manuscript. 2026.PMCID: PMC13484932 -
Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial.
- Jhaveri KL, Neven P, Casalnuovo ML, Kim SB, Tokunaga E, Aftimos P, Saura C, O'Shaughnessy J, Harbeck N, Carey LA, Curigliano G, Watanabe J, Lim E, Huang J, Qingyuan Z, Llombart-Cussac A, Huang C, Desai B, Limay Y, Wang XA, Cao S, Bidard FC.
- Ann Oncol. Author manuscript. 2025 Dec 12;37(4):532-543. doi: 10.1016/j.annonc.2025.11.018.
- PMCID: PMC13485152
Jhaveri KL, et al.Ann Oncol. Author manuscript. 2025.PMCID: PMC13485152 -
Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study.
- Motzer RJ, Albiges L, Treviño Aguirre SA, Kanesvaran R, Centkowski P, Reimers MA, Sade JP, Pouessel D, Biscaldi E, Esteban E, Arranz Arija JÁ, Tykodi SS, van Kooten Losio M, Dighe A, Ma H, Valmeekam V, Simmons A, Scheffold C, Andrianova S, Braun DA, Powles T, Choueiri TK.
- Ann Oncol. Author manuscript. 2026 Feb 18;37(6):861-871. doi: 10.1016/j.annonc.2026.02.011.
- PMCID: PMC13463394
Motzer RJ, et al.Ann Oncol. Author manuscript. 2026.PMCID: PMC13463394 -
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.
- Tripathi A, Chen Y, Jarrard DF, Garcia JA, Dreicer R, Liu G, Hussain MH, Shevrin DH, Cooney M, Eisenberger MA, Kohli M, Plimack ER, Vogelzang NJ, Picus J, Carducci MA, DiPaola RS, Sweeney CJ.
- Ann Oncol. Author manuscript. 2025 Aug 23;36(11):1409-1413. doi: 10.1016/j.annonc.2025.08.004.
- PMCID: PMC13397343
Tripathi A, et al.Ann Oncol. Author manuscript. 2025.PMCID: PMC13397343